Sat.Jul 20, 2024

article thumbnail

Opinion: Readers respond to essays on philanthropy and nursing schools, opioid overdoses, and more

STAT

First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.

article thumbnail

Which pharmaceutical companies have the most SPCs in Romania?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Romania.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Is Emergency Medicine Pharmacy Right For You?

The Happy PharmD

Are you curious about emergency medicine pharmacy and whether or not it’s something that you should consider as a career choice? Well, you’re not alone. Lots of other people have thought the same thing, and in this discussion, we’ll dive into the nitty-gritty details — the pros, the cons, the salary, the satisfaction, the job demand, and of course, the flexibility of having this career path as a pharmacist.

article thumbnail

New tentative approval for Alembic drug dabigatran etexilate mesylate

Drug Patent Watch

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.

52
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Kadimastem and Pluri Enter Cell Therapy Manufacturing Deal

PharmaTech

PluriCDMO, Pluri's newly launched CMDO division, has been selected by Kadimastem to manufacture two novel cell therapy product candidates.

52
article thumbnail

Trump campaign provides new details on his ear wound and treatment

STAT

WASHINGTON — Former President Donald Trump is doing well and required no stitches after a gunshot at his campaign rally last weekend grazed his ear, his former White House doctor said in a memo released Saturday by Trump’s campaign. The bullet passed less than a quarter inch from the former president’s head, causing a two-centimeter-wide wound and “significant bleeding, followed by marked swelling of the entire upper ear,” Rep.

328
328